Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atai Life Sciences N.V.
(NQ:
ATAI
)
1.310
+0.020 (+1.55%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Atai Life Sciences N.V.
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
March 27, 2023
Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 27, 2023
March 27, 2023
Via
Benzinga
Expert Ratings for ATAI Life Sciences
March 27, 2023
Via
Benzinga
ATAI Life Sciences Earnings Perspective: Return On Capital Employed
March 27, 2023
Via
Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today
March 24, 2023
Via
Benzinga
Atai Life Sciences Hopes Hercules Can Help 'Sustain' Operations Until 2026
March 24, 2023
Biopharma company Atai Life Sciences' (NASDAQ: ATAI) fourth quarter and full year 2022 consolidated financial results show:
Via
Benzinga
The Latest Analyst Ratings for ATAI Life Sciences
March 07, 2023
Via
Benzinga
atai Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Pipeline Highlights
March 24, 2023
From
atai Life Sciences
Via
GlobeNewswire
GH Research, Compass Pathways Among Top Psychedelic Movers Of Today
March 23, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 22, 2023
March 22, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 21, 2023
March 21, 2023
Via
Benzinga
EXCLUSIVE: NYC Ketamine Center Co-Founder On Prices, Insurance, Competition & Expansion
March 21, 2023
This is the third article of a three-part series, you can find the first and
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 20, 2023
March 20, 2023
Via
Benzinga
An Update On The Performance Of The 7 Largest Psychedelic Stocks
March 19, 2023
The 7 largest psychedelic drug stocks are ranked as to their stock performances since the beginning of March and year-to-date, their likelihood of financial distress, analyst price forecasts and the...
Via
Talk Markets
The "Rags-To-Riches" Portfolio: An Update
March 18, 2023
Cannabis, psychedelic, and plant-based food stocks performed extremely poorly in 2022, down 73% vs. 2021 but perhaps some of them will bounce back with major returns in 2023.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From March 17, 2023
March 17, 2023
Via
Benzinga
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
March 16, 2023
Via
Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
March 15, 2023
Via
Benzinga
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
March 14, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 14, 2023
Tuesday's morning session saw 84 companies set new 52-week lows.
Via
Benzinga
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today
March 13, 2023
Via
Benzinga
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
March 13, 2023
Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial
Via
Benzinga
Major Psychedelics VC & EFT Directors Will Share Valuable Insights At Upcoming Benzinga Event
March 13, 2023
The Benzinga Psychedelics Capital Conference (PCC) is rapidly becoming the place to be for all those interested or involved in the space. In addition to being the place where deals are done, you'll...
Via
Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
March 10, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 9, 2023
March 09, 2023
Via
Benzinga
Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today
March 08, 2023
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
March 07, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 6, 2023
March 06, 2023
Via
Benzinga
Atai Update: Ketamine Trials Are Ongoing, Company Cuts 30% Workforce
March 06, 2023
The clinical-stage biopharma company atai Life Sciences (NASDAQ: ATAI) founded in 2018 shared updates on the two clinical trials as well as its plan to streamline its workforce with significant...
Via
Benzinga
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
March 06, 2023
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.